A Tennessee maker of wheelchair components received an FDA warning letter after the agency found problems with the company’s documentation and complaint-handling procedures. According to the July 27 letter, AireRx Healthcare did not evaluate complaints to determine if they represented MDR-reportable events.
The GMP Letter